These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 24445297)
1. Commentary on "common genetic polymorphisms modify the effect of smoking on absolute risk of bladder cancer." Garcia-Closas M, Rothman N, Figueroa JD, Prokunina-Olsson L, Han SS, Baris D, Jacobs EJ, Malats N, De Vivo I, Albanes D, Purdue MP, Sharma S, Fu YP, Kogevinas M, Wang Z, Tang W, Tardón A, Serra C, Carrato A, García-Closas R, Lloreta J, Johnson A, Schwenn M, Karagas MR, Schned A, Andriole G Jr., Grubb R 3rd, Black A, Gapstur SM, Thun M, Diver WR, Weinstein SJ, Virtamo J, Hunter DJ, Caporaso N, Landi MT, Hutchinson A, Burdett L, Jacobs KB, Yeager M, Fraumeni JF Jr., Chanock SJ, Silverman DT, Chatterjee N, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.: Cancer Res 2013;73(7):2211-20 [Epub 2013 Mar 27]. Scherr DS Urol Oncol; 2014 Feb; 32(2):213-4. PubMed ID: 24445297 [TBL] [Abstract][Full Text] [Related]
2. Common genetic polymorphisms modify the effect of smoking on absolute risk of bladder cancer. Garcia-Closas M; Rothman N; Figueroa JD; Prokunina-Olsson L; Han SS; Baris D; Jacobs EJ; Malats N; De Vivo I; Albanes D; Purdue MP; Sharma S; Fu YP; Kogevinas M; Wang Z; Tang W; Tardón A; Serra C; Carrato A; García-Closas R; Lloreta J; Johnson A; Schwenn M; Karagas MR; Schned A; Andriole G; Grubb R; Black A; Gapstur SM; Thun M; Diver WR; Weinstein SJ; Virtamo J; Hunter DJ; Caporaso N; Landi MT; Hutchinson A; Burdett L; Jacobs KB; Yeager M; Fraumeni JF; Chanock SJ; Silverman DT; Chatterjee N Cancer Res; 2013 Apr; 73(7):2211-20. PubMed ID: 23536561 [TBL] [Abstract][Full Text] [Related]
3. Commentary on "identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array." Eeles RA, Olama AA, Benlloch S, Saunders EJ, Leongamornlert DA, Tymrakiewicz M, Ghoussaini M, Luccarini C, Dennis J, Jugurnauth-Little S, Dadaev T, Neal DE, Hamdy FC, Donovan JL, Muir K, Giles GG, Severi G, Wiklund F, Gronberg H, Haiman CA, Schumacher F, Henderson BE, Le Marchand L, Lindstrom S, Kraft P, Hunter DJ, Gapstur S, Chanock SJ, Berndt SI, Albanes D, Andriole G, Schleutker J, Weischer M, Canzian F, Riboli E, Key TJ, Travis RC, Campa D, Ingles SA, John EM, Hayes RB, Pharoah PD, Pashayan N, Khaw KT, Stanford JL, Ostrander EA, Signorello LB, Thibodeau SN, Schaid D, Maier C, Vogel W, Kibel AS, Cybulski C, Lubinski J, Cannon-Albright L, Brenner H, Park JY, Kaneva R, Batra J, Spurdle AB, Clements JA, Teixeira MR, Dicks E, Lee A, Dunning AM, Baynes C, Conroy D, Maranian MJ, Ahmed S, Govindasami K, Guy M, Wilkinson RA, Sawyer EJ, Morgan A, Dearnaley DP, Horwich A, Huddart RA, Khoo VS, Parker CC, Van As NJ, Woodhouse CJ, Thompson A, Dudderidge T, Ogden C, Cooper CS, Lophatananon A, Cox A, Southey MC, Hopper JL, English DR, Aly M, Adolfsson J, Xu J, Zheng SL, Yeager M, Kaaks R, Diver WR, Gaudet MM, Stern MC, Corral R, Joshi AD, Shahabi A, Wahlfors T, Tammela TL, Auvinen A, Virtamo J, Klarskov P, Nordestgaard BG, Røder MA, Nielsen SF, Bojesen SE, Siddiq A, Fitzgerald LM, Kolb S, Kwon EM, Karyadi DM, Blot WJ, Zheng W, Cai Q, McDonnell SK, Rinckleb AE, Drake B, Colditz G, Wokolorczyk D, Stephenson RA, Teerlink C, Muller H, Rothenbacher D, Sellers TA, Lin HY, Slavov C, Mitev V, Lose F, Srinivasan S, Maia S, Paulo P, Lange E, Cooney KA, Antoniou AC, Vincent D, Bacot F, Tessier DC; COGS-Cancer Research UK GWAS-ELLIPSE (part of GAME-ON) Initiative; Australian Prostate Cancer Bioresource; UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of Oncology; UK ProtecT (Prostate testing for cancer and Treatment) Study. Olumi AF Urol Oncol; 2014 Feb; 32(2):211. PubMed ID: 24445293 [TBL] [Abstract][Full Text] [Related]
4. Evaluating interactions of polygenic risk scores and NAT2 genotypes with tobacco smoking in bladder cancer risk. Pradhan P; Jia G; Khankari NK; Zheng W Int J Cancer; 2024 Jan; 154(2):210-216. PubMed ID: 37728483 [TBL] [Abstract][Full Text] [Related]
5. Commentary on "Plasma carotenoids and vitamin C concentrations and risk of urothelial cell carcinoma in the European Prospective Investigation into Cancer and Nutrition." Ros MM, Bueno de Mesquita HB, Kampman E, Aben KK, Büchner FL, Jansen EH, van Gils CH, Egevad L, Overvad K, Tjønneland A, Roswall N, Boutron Ruault MC, Kvaskoff M, Perquier F, Kaaks R, Chang Claude J, Weikert S, Boeing H, Trichopoulou A, Lagiou P, Dilis V, Palli D, Pala V, Sacerdote C, Tumino R, Panico S, Peeters PH, Gram IT, Skeie G, Huerta JM, Barricarte A, Quirós JR, Sánchez MJ, Buckland G, Larrañaga N, Ehrnström R, Wallström P, Ljungberg B, Hallmans G, Key TJ, Allen NE, Khaw KT, Wareham N, Brennan P, Riboli E, Kiemeney LA, National Institute for Public Health and the Environment, Bilthoven, Netherlands: Am J Clin Nutr 2012;96(4):902-10 [Epub 2012 Sep 5]. See WA Urol Oncol; 2013 Jul; 31(5):714-5. PubMed ID: 23796198 [TBL] [Abstract][Full Text] [Related]
6. XPD codon 751 polymorphism, metabolism genes, smoking, and bladder cancer risk. Stern MC; Johnson LR; Bell DA; Taylor JA Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1004-11. PubMed ID: 12376500 [TBL] [Abstract][Full Text] [Related]
7. GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study. Matic M; Pekmezovic T; Djukic T; Mimic-Oka J; Dragicevic D; Krivic B; Suvakov S; Savic-Radojevic A; Pljesa-Ercegovac M; Tulic C; Coric V; Simic T Urol Oncol; 2013 Oct; 31(7):1184-92. PubMed ID: 24075358 [TBL] [Abstract][Full Text] [Related]
8. Genome-wide Association Study of Bladder Cancer Reveals New Biological and Translational Insights. Koutros S; Kiemeney LA; Pal Choudhury P; Milne RL; Lopez de Maturana E; Ye Y; Joseph V; Florez-Vargas O; Dyrskjøt L; Figueroa J; Dutta D; Giles GG; Hildebrandt MAT; Offit K; Kogevinas M; Weiderpass E; McCullough ML; Freedman ND; Albanes D; Kooperberg C; Cortessis VK; Karagas MR; Johnson A; Schwenn MR; Baris D; Furberg H; Bajorin DF; Cussenot O; Cancel-Tassin G; Benhamou S; Kraft P; Porru S; Carta A; Bishop T; Southey MC; Matullo G; Fletcher T; Kumar R; Taylor JA; Lamy P; Prip F; Kalisz M; Weinstein SJ; Hengstler JG; Selinski S; Harland M; Teo M; Kiltie AE; Tardón A; Serra C; Carrato A; García-Closas R; Lloreta J; Schned A; Lenz P; Riboli E; Brennan P; Tjønneland A; Otto T; Ovsiannikov D; Volkert F; Vermeulen SH; Aben KK; Galesloot TE; Turman C; De Vivo I; Giovannucci E; Hunter DJ; Hohensee C; Hunt R; Patel AV; Huang WY; Thorleifsson G; Gago-Dominguez M; Amiano P; Golka K; Stern MC; ; Yan W; Liu J; Li SA; Katta S; Hutchinson A; Hicks B; Wheeler WA; Purdue MP; McGlynn KA; Kitahara CM; Haiman CA; Greene MH; Rafnar T; Chatterjee N; Chanock SJ; Wu X; Real FX; Silverman DT; Garcia-Closas M; Stefansson K; Prokunina-Olsson L; Malats N; Rothman N Eur Urol; 2023 Jul; 84(1):127-137. PubMed ID: 37210288 [TBL] [Abstract][Full Text] [Related]
9. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. García-Closas M; Malats N; Silverman D; Dosemeci M; Kogevinas M; Hein DW; Tardón A; Serra C; Carrato A; García-Closas R; Lloreta J; Castaño-Vinyals G; Yeager M; Welch R; Chanock S; Chatterjee N; Wacholder S; Samanic C; Torà M; Fernández F; Real FX; Rothman N Lancet; 2005 Aug 20-26; 366(9486):649-59. PubMed ID: 16112301 [TBL] [Abstract][Full Text] [Related]
10. Commentary on "Reproductive factors and kidney cancer risk in 2 US cohort studies, 1993-2010." Karami S, Daugherty SE, Schonfeld SJ, Park Y, Hollenbeck AR, Grubb RL 3rd, Hofmann JN, Chow WH, Purdue MP, Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, MD. Am J Epidemiol 2013; 177(12):1368-77. [Epub 2013 Apr 26]. doi: 10.1093/aje/kws406. Boorjian S Urol Oncol; 2014 Aug; 32(6):932-3. PubMed ID: 25087669 [TBL] [Abstract][Full Text] [Related]
11. Interactions between cigarette smoking and XPC-PAT genetic polymorphism enhance bladder cancer risk. Liu Y; Wang H; Lin T; Wei Q; Zhi Y; Yuan F; Song B; Yang J; Chen Z Oncol Rep; 2012 Jul; 28(1):337-45. PubMed ID: 22505326 [TBL] [Abstract][Full Text] [Related]
12. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking. Okkels H; Sigsgaard T; Wolf H; Autrup H Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426 [TBL] [Abstract][Full Text] [Related]
13. N-acetyltransferase 2 and bladder cancer: an overview and consideration of the evidence for gene-environment interaction. Green J; Banks E; Berrington A; Darby S; Deo H; Newton R Br J Cancer; 2000 Aug; 83(3):412-7. PubMed ID: 10917561 [TBL] [Abstract][Full Text] [Related]
14. Current smoking, occupation, N-acetyltransferase-2 and bladder cancer: a pooled analysis of genotype-based studies. Vineis P; Marinelli D; Autrup H; Brockmoller J; Cascorbi I; Daly AK; Golka K; Okkels H; Risch A; Rothman N; Sim E; Taioli E Cancer Epidemiol Biomarkers Prev; 2001 Dec; 10(12):1249-52. PubMed ID: 11751441 [TBL] [Abstract][Full Text] [Related]
15. Genome-wide interaction study of smoking and bladder cancer risk. Figueroa JD; Han SS; Garcia-Closas M; Baris D; Jacobs EJ; Kogevinas M; Schwenn M; Malats N; Johnson A; Purdue MP; Caporaso N; Landi MT; Prokunina-Olsson L; Wang Z; Hutchinson A; Burdette L; Wheeler W; Vineis P; Siddiq A; Cortessis VK; Kooperberg C; Cussenot O; Benhamou S; Prescott J; Porru S; Bueno-de-Mesquita HB; Trichopoulos D; Ljungberg B; Clavel-Chapelon F; Weiderpass E; Krogh V; Dorronsoro M; Travis R; Tjønneland A; Brenan P; Chang-Claude J; Riboli E; Conti D; Gago-Dominguez M; Stern MC; Pike MC; Van Den Berg D; Yuan JM; Hohensee C; Rodabough R; Cancel-Tassin G; Roupret M; Comperat E; Chen C; De Vivo I; Giovannucci E; Hunter DJ; Kraft P; Lindstrom S; Carta A; Pavanello S; Arici C; Mastrangelo G; Karagas MR; Schned A; Armenti KR; Hosain GM; Haiman CA; Fraumeni JF; Chanock SJ; Chatterjee N; Rothman N; Silverman DT Carcinogenesis; 2014 Aug; 35(8):1737-44. PubMed ID: 24662972 [TBL] [Abstract][Full Text] [Related]
16. Bladder Cancer Working Group report. Kakehi Y; Hirao Y; Kim WJ; Ozono S; Masumori N; Miyanaga N; Nasu Y; Yokomizo A Jpn J Clin Oncol; 2010 Sep; 40 Suppl 1():i57-64. PubMed ID: 20870921 [TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in GSTT1, GSTM1, NAT1 and NAT2 genes and bladder cancer risk in men and women. McGrath M; Michaud D; De Vivo I BMC Cancer; 2006 Oct; 6():239. PubMed ID: 17026750 [TBL] [Abstract][Full Text] [Related]
18. Concordance of multiple analytical approaches demonstrates a complex relationship between DNA repair gene SNPs, smoking and bladder cancer susceptibility. Andrew AS; Nelson HH; Kelsey KT; Moore JH; Meng AC; Casella DP; Tosteson TD; Schned AR; Karagas MR Carcinogenesis; 2006 May; 27(5):1030-7. PubMed ID: 16311243 [TBL] [Abstract][Full Text] [Related]
19. GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population. Hung RJ; Boffetta P; Brennan P; Malaveille C; Hautefeuille A; Donato F; Gelatti U; Spaliviero M; Placidi D; Carta A; Scotto di Carlo A; Porru S Int J Cancer; 2004 Jul; 110(4):598-604. PubMed ID: 15122594 [TBL] [Abstract][Full Text] [Related]
20. Comparing the joint effect of arsenic exposure, cigarette smoking and risk genotypes of vascular endothelial growth factor on upper urinary tract urothelial carcinoma and bladder cancer. Wang YH; Yeh SD; Wu MM; Liu CT; Shen CH; Shen KH; Pu YS; Hsu LI; Chiou HY; Chen CJ J Hazard Mater; 2013 Nov; 262():1139-46. PubMed ID: 23009795 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]